INTERVIEW · HEALTH · AstraZeneca · Milken Global Conference 2025 · 13:24 · Released September 30, 2026
"The idea that one cancer drug can help most patients is no longer real." - Milken Global 2025
AstraZeneca’s Chief Medical Officer on combining antibody-drug conjugates, targeted therapy and immunotherapy, precision oncology, and the one AI tool still missing: a model that predicts whether a clinical trial will succeed.
HealthcareAIScience
Up next
More like this11:19
Technology, Cloud and the Future, GCC Conclave 2019
Ian Khan · GCC Conclave 2019
3:43
Reducing the Friction Between Government and People | Ian Khan at WGS 2024
Government Experience
9:26
Applying 'Never Events' Thinking to Clinical AI | Dr Erin Palm, Infinitus
ViVE 2026
9:04
It Is Impossible to Debank Someone | Dom Kwok, EasyA
Consensus 2025 Toronto
8:32
Ophir Kagan, Co-Founder & CEO of Maitri Health at HLTH2025 with Ian Khan
HLTH 2025
12:38
We Are Automating on Top of Trust We Never Had | Tricia Wang
Consensus 2025 Toronto
7:18
Jenna DiRito, Co-Founder & COO of Revalia Bio at HLTH2025 with Ian Khan
HLTH 2025
9:38
Data Is Oil, and We Like to Be Fracking | Kempton Presley, AdhereHealth
ViVE 2026
11:13
"53% of leaders want more productivity while 80% of workers say they're maxed out." - Milken Global 2025
Microsoft · Milken Global Conference 2025
9:28
American Medicine Is the Best in the World. The System Is Not | Malinka Walaliyadde, AKASA
ViVE 2026